During the past decade, Hospital Universitario de Torrejón conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 7 clinical trials were completed, i.e. on average, 20.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 6 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Torrejón" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Barcelona Institute for Global Health" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Torrejón" #1 collaborator was "Hospital Sant Joan de Deu" with 2 trials as a collaborator, "Hospital Universitario Infanta Leonor" with 2 trials as a collaborator, "Hospital Universitario de Torrejón" with 2 trials as a collaborator, "Hospital del Mar" with 2 trials as a collaborator and "Sanofi" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Torrejón" are "Crohn's Disease" (3 trials), "Perioperative Care" (3 trials), "Postoperative Complications" (3 trials), "Ulcerative Colitis" (3 trials) and "COVID" (2 trials). Many other conditions were trialed in "Hospital Universitario de Torrejón" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Torrejón" are "Drug" (21 trials), "Biological" (4 trials), "Other" (3 trials), "Procedure" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Guselkumab" (4 trials), "Golimumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Torrejón" are 29 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario de Torrejón". 1 are not yet recruiting, 13 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Hospital Universitario de Torrejón, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Torrejón, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".